BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2577707)

  • 1. Peripheral vascular effects of dopexamine hydrochloride during cardiopulmonary bypass.
    Siemons AW; van der Starre PJ
    J Cardiothorac Anesth; 1989 Oct; 3(5 Suppl 1):14. PubMed ID: 2577707
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemodynamic effects of dopexamine hydrochloride administered by an intracoronary infusion technique.
    Demeyere R; Flameng W; Lunkenheimer P
    J Cardiothorac Anesth; 1989 Oct; 3(5 Suppl 1):15. PubMed ID: 2577708
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of dopexamine hydrochloride in patients with low cardiac output after cardiac surgery.
    Du Gres B; Flamens C; Gruner MC
    J Cardiothorac Anesth; 1989 Oct; 3(5 Suppl 1):16. PubMed ID: 2577709
    [No Abstract]   [Full Text] [Related]  

  • 4. Prolonged infusion of varied doses of dopexamine hydrochloride for low cardiac output after cardiac surgery.
    Santman FW
    J Cardiothorac Vasc Anesth; 1992 Oct; 6(5):568-72. PubMed ID: 1358247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged infusion of varied doses of dopexamine hydrochloride for circulatory failure after cardiac surgery.
    Santman FW; Thomas SM; Hoskins B
    J Cardiothorac Anesth; 1989 Oct; 3(5 Suppl 1):13. PubMed ID: 2577706
    [No Abstract]   [Full Text] [Related]  

  • 6. Dopexamine hydrochloride, a novel drug with renal vasodilator properties: two case studies.
    Bodenham AR; Park GR
    Intensive Care Med; 1988; 14(6):663-5. PubMed ID: 3183194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopexamine hydrochloride: pharmacology and use in low cardiac output states.
    Ghosh S; Gray B; Oduro A; Latimer RD
    J Cardiothorac Vasc Anesth; 1991 Aug; 5(4):382-9. PubMed ID: 1678660
    [No Abstract]   [Full Text] [Related]  

  • 8. Recommendations for the treatment of patients with septic shock.
    Meier-Hellmann A; Reinhart K
    Acta Anaesthesiol Scand Suppl; 1997; 111():177-80. PubMed ID: 9421002
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of dopexamine hydrochloride as an anti-hypertensive agent after cardiac surgery.
    Colvin JR; Chaudhri S; Kenny GN
    Int J Clin Monit Comput; 1991; 8(2):95-100. PubMed ID: 1683886
    [No Abstract]   [Full Text] [Related]  

  • 10. Hemodynamic effects of dopexamine in patients following coronary artery bypass surgery.
    Poelaert JI; Mungroop HE; Koolen JJ; Van den Berg PC
    J Cardiothorac Anesth; 1989 Aug; 3(4):441-3. PubMed ID: 2577703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amrinone versus dopamine and nitroglycerin in neonates after arterial switch operation for transposition of the great arteries.
    Laitinen P; Happonen JM; Sairanen H; Peltola K; Rautiainen P
    J Cardiothorac Vasc Anesth; 1999 Apr; 13(2):186-90. PubMed ID: 10230954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of dopexamine hydrochloride on cardiopulmonary haemodynamics following cardiopulmonary bypass surgery.
    Hunter DN; Gray H; Mudaliar Y; Morgan C; Evans TW
    Int J Cardiol; 1989 Jun; 23(3):365-71. PubMed ID: 2567710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dopexamine: a new dopaminergic agonist].
    Perrin G; Papazian L; Martin C
    Ann Fr Anesth Reanim; 1993; 12(3):308-20. PubMed ID: 7902685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effects of dopexamine HCl in conscious and halothane-anaesthetised horses.
    Muir WW
    Equine Vet J Suppl; 1992 Feb; (11):24-9. PubMed ID: 9109955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of fenoldopam and dopexamine on hepatic blood flow and hepatic function following coronary artery bypass grafting with hypothermic cardiopulmonary bypass.
    Adluri RK; Singh AV; Skoyles J; Robins A; Hitch A; Baker M; Mitchell IM
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):988-94. PubMed ID: 19406658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The haemodynamic effect of prophylactic peri-operative dopexamine in coronary artery bypass patients.
    Hurley J; McDonagh P; Cahill M; White M; Luke D; McGovern E; Phelan D
    Eur Heart J; 1995 Nov; 16(11):1705-9. PubMed ID: 8881868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the efficacy of dopexamine and dobutamine for increasing oxygen delivery in high-risk surgical patients.
    Boyd O; Lamb G; Mackay CJ; Grounds RM; Bennett ED
    Anaesth Intensive Care; 1995 Aug; 23(4):478-84. PubMed ID: 7485941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inotropic mechanisms of dopexamine hydrochloride in horses.
    Muir WW
    Am J Vet Res; 1992 Aug; 53(8):1343-6. PubMed ID: 1354950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inotropic, vascular and neuroendocrine effects of dopexamine hydrochloride and comparison with dobutamine.
    Jaski BE; Peters C
    Am J Cardiol; 1988 Aug; 62(5):63C-67C. PubMed ID: 3407597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing liver blood flow after cardiopulmonary bypass: the effects of dopamine and dopexamine.
    Sharpe DA; Mitchel IM; Kay EA; McGoldrick JP; Munsch CM; Kay PH
    Perfusion; 1999 Jan; 14(1):29-36. PubMed ID: 10074644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.